PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

about

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q54978311

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@en

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@nl

type

Item

label

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@en

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@nl

prefLabel

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@en

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

@nl

P1476

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

@en

P2093

Caroline Spasojevic

http://www.w3.org/2001/XMLSchema#string

Christian Auclair

http://www.w3.org/2001/XMLSchema#string

Didier Meseure

http://www.w3.org/2001/XMLSchema#string

Franck Assayag

http://www.w3.org/2001/XMLSchema#string

Jean Marc Ricort

http://www.w3.org/2001/XMLSchema#string

Manale Karam

http://www.w3.org/2001/XMLSchema#string

Marie Regairaz

http://www.w3.org/2001/XMLSchema#string

Martine Humbert

http://www.w3.org/2001/XMLSchema#string

Sophie Château-Joubert

http://www.w3.org/2001/XMLSchema#string

Sophie Vacher

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular profiling of patient-derived breast cancer xenografts

Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Molecular portraits of human breast tumours

Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.

SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest

Triple-Negative Breast Cancer

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.

Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.

P304

23208-23219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25292

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ivan Bieche

Elisabetta Marangoni

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29796183

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5955414

http://www.w3.org/2001/XMLSchema#string